COVID-19 is an emerging, rapidly evolving siituation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Announcing the Launch of CPTAC’s Proteogenomics DREAM Challenge

This week, we are excited to announce the launch of the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Proteogenomics Computational DREAM Challenge.  The aim of this Challenge is to encourage the generation of computational methods for extracting information from the cancer proteome and for linking those data to genomic and transcriptomic information.  The specific goals are to predict proteomic and phosphoproteomic data from other multiple data types including transcriptomics and genetics.

DREAM Challenges are community-based, collaborative competitions run by researchers and organizations in their respective fields.  With crowdsourcing, CPTAC hopes to find the best answers to some elusive questions in the field, and advance the fight against cancer.

DREAM Challenge will be run in the Google Cloud, and provide a prize award sponsored by the NVIDIA Foundation.  Nature Methods also supports the submission of an overview paper of the Challenge, contingent on a standard evaluation process.

Join us at: click here.

NCI-CPTAC DREAM Proteogenomics Challenge